Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

1.7K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.7K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

1.1K
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Folate-Functionalized Albumin-Containing Systems: Non-Covalent vs. Covalent Binding of Folic Acid.

Pharmaceutics·2026
Same author

KRASAVA-An Expert System for Virtual Screening of KRAS G12D Inhibitors.

International journal of molecular sciences·2026
Same author

Folate-Modified Albumin-Functionalized Iron Oxide Nanoparticles for Theranostics: Engineering and In Vitro PDT Treatment of Breast Cancer Cell Lines.

Pharmaceutics·2025
Same author

ToxAI_assistant: a web platform for a comprehensive study of the acute toxicity of xenobiotics following oral and intravenous administration in rats.

SAR and QSAR in environmental research·2025
Same author

HDAC6 detector: online application for evaluating compounds as potential histone deacetylase 6 inhibitors.

SAR and QSAR in environmental research·2023
Same author

HDAC1 PREDICTOR: a simple and transparent application for virtual screening of histone deacetylase 1 inhibitors.

SAR and QSAR in environmental research·2022

相关实验视频

Updated: Apr 28, 2026

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
11:06

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

6.2K

HT_PREDICT:基于机器学习的计算开源工具,用于选HDAC6抑制剂.

O V Tinkov1, V N Osipov2, A V Kolotaev3

  • 1Department of Pharmacology and Pharmaceutical Chemistry, Medical Faculty, Shevchenko Transnistria State University, Tiraspol, Moldova.

SAR and QSAR in environmental research
|July 15, 2024
PubMed
概括

研究人员开发了定量结构-活性关系 (QSAR) 模型,以识别选择性激素脱乙酶6 (HDAC6) 抑制剂,用于治疗癌症和神经退行性疾病. 这些模型可以通过HT_PREDICT网络应用程序获得,以帮助药物发现.

关键词:
在QSAR中使用QSAR.简化简化简化简化简化剧烈毒性的急性毒性机器学习是机器学习.分子指纹,分子指纹.选择性抑制剂 选择性抑制剂

更多相关视频

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
09:20

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Published on: August 10, 2017

8.5K
Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

6.5K

相关实验视频

Last Updated: Apr 28, 2026

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
11:06

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

6.2K
Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
09:20

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Published on: August 10, 2017

8.5K
Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

6.5K

科学领域:

  • 药用化学 医学化学
  • 计算化学计算化学
  • 药物发现 药物发现 药物发现

背景情况:

  • 基斯脱乙酶6 (HDAC6) 是癌症和神经退行性疾病 (如阿尔茨海默病) 的关键治疗点.
  • 开发有选择性和无毒的HDAC6抑制剂对于有效的治疗策略至关重要.

研究的目的:

  • 创建强大的定量结构-活性关系 (QSAR) 模型来预测HDAC6抑制剂.
  • 将这些QSAR模型集成到一个用户友好的网络应用程序中,用于虚拟选.

主要方法:

  • 利用3854个化合物的数据集,使用PubChem和Klekota-Roth数据与2D原子对指纹和RDKit描述符.
  • 应用机器学习算法,包括梯度提升,支持向量机,神经网络和k-最近邻居.
  • 开发了HT_PREDICT网络应用程序 (https://htpredict.streamlit.app/) 来托管QSAR模型.

主要成果:

  • 建立了经过验证的回归QSAR模型,通过体外研究证实了预测准确度.
  • 该HT_PREDICT应用程序成功执行了化合物的虚拟选.
  • 确定了两种新的,有前途的HDAC6抑制剂,用于未来的临床前研究.

结论:

  • 开发的QSAR模型和HT_PREDICT应用程序为识别潜在的HDAC6抑制剂提供了宝贵的工具.
  • 这种方法加速了与HDAC6失调相关的疾病的药物发现过程.
  • 已识别的化合物需要进一步研究以开发治疗方法.